BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 29879503)

  • 1. The reciprocal link between EVI1 and miRNAs in human malignancies.
    Lang WJ; Chen FY
    Gene; 2018 Sep; 672():56-63. PubMed ID: 29879503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EVI1 dysregulation: impact on biology and therapy of myeloid malignancies.
    Birdwell C; Fiskus W; Kadia TM; DiNardo CD; Mill CP; Bhalla KN
    Blood Cancer J; 2021 Mar; 11(3):64. PubMed ID: 33753715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EVI1 promotes cell proliferation in HBx-induced hepatocarcinogenesis as a critical transcription factor regulating lncRNAs.
    Huang JF; Wang Y; Liu F; Liu Y; Zhao CX; Guo YJ; Sun SH
    Oncotarget; 2016 Apr; 7(16):21887-99. PubMed ID: 26967394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myeloid leukemia with high EVI1 expression is sensitive to 5-aza-2'-deoxycytidine by targeting miR-9.
    Li F; He W; Geng R; Xie X
    Clin Transl Oncol; 2020 Jan; 22(1):137-143. PubMed ID: 31054042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ecotropic viral integration site 1 regulates EGFR transcription in glioblastoma cells.
    Mizuguchi A; Yamashita S; Yokogami K; Morishita K; Takeshima H
    J Neurooncol; 2019 Nov; 145(2):223-231. PubMed ID: 31617054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imbalanced expression of polycistronic miRNA in acute myeloid leukemia.
    Kotaki R; Higuchi H; Ogiya D; Katahira Y; Kurosaki N; Yukihira N; Ogata J; Yamamoto H; Mohamad Alba S; Azhim A; Kitajima T; Inoue S; Morishita K; Ono K; Koyama-Nasu R; Kotani A
    Int J Hematol; 2017 Dec; 106(6):811-819. PubMed ID: 28831750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-133 regulates Evi1 expression in AML cells as a potential therapeutic target.
    Yamamoto H; Lu J; Oba S; Kawamata T; Yoshimi A; Kurosaki N; Yokoyama K; Matsushita H; Kurokawa M; Tojo A; Ando K; Morishita K; Katagiri K; Kotani A
    Sci Rep; 2016 Jan; 6():19204. PubMed ID: 26754824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of miR-96/EVI1/miR-449a Axis in the Nasopharyngeal Carcinoma Cell Migration and Tumor Sphere Formation.
    Chan LS; Lung HL; Ngan RK; Lee AW; Tsao SW; Lo KW; Kahn M; Lung ML; Wieser R; Mak NK
    Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32752071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Chromosomal rearrangements between 3q21 and 3q26 induce leukemogenesis by misdirecting both EVI1 and GATA2 genes].
    Suzuki M
    Rinsho Ketsueki; 2017; 58(7):806-812. PubMed ID: 28781278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiRNAs and E2F3: a complex network of reciprocal regulations in human cancers.
    Gao Y; Feng B; Lu L; Han S; Chu X; Chen L; Wang R
    Oncotarget; 2017 Sep; 8(36):60624-60639. PubMed ID: 28947999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Understanding the CREB1-miRNA feedback loop in human malignancies.
    Wang YW; Chen X; Ma R; Gao P
    Tumour Biol; 2016 Jul; 37(7):8487-502. PubMed ID: 27059735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional features of EVI1 and EVI1Δ324 isoforms of MECOM gene in genome-wide transcription regulation and oncogenicity.
    Sayadi A; Jeyakani J; Seet SH; Wei CL; Bourque G; Bard FA; Jenkins NA; Copeland NG; Bard-Chapeau EA
    Oncogene; 2016 May; 35(18):2311-21. PubMed ID: 26234679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EVI1 overexpression promotes ovarian cancer progression by regulating estrogen signaling.
    Wang Z; Li Y; Wang N; Li P; Kong B; Liu Z
    Mol Cell Endocrinol; 2021 Aug; 534():111367. PubMed ID: 34146645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amplification of MDS1/EVI1 and EVI1, located in the 3q26.2 amplicon, is associated with favorable patient prognosis in ovarian cancer.
    Nanjundan M; Nakayama Y; Cheng KW; Lahad J; Liu J; Lu K; Kuo WL; Smith-McCune K; Fishman D; Gray JW; Mills GB
    Cancer Res; 2007 Apr; 67(7):3074-84. PubMed ID: 17409414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EVI1 induces autophagy to promote drug resistance via regulation of ATG7 expression in leukemia cells.
    Niu Y; Yang X; Chen Y; Jin X; Li L; Guo Y; Li X; Xie Y; Zhang Y; Wang H
    Carcinogenesis; 2020 Jul; 41(7):961-971. PubMed ID: 31593983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EVI‑1 acts as an oncogene and positively regulates calreticulin in breast cancer.
    Wu L; Wang T; He D; Li X; Jiang Y
    Mol Med Rep; 2019 Mar; 19(3):1645-1653. PubMed ID: 30592274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ecotopic viral integration site 1 (EVI1) transcriptionally targets talin1 (TLN1) and upregulates its expression in chronic myeloid leukemia.
    Halder A; Nayak KB; Chakraborty S
    Leuk Lymphoma; 2018 Aug; 59(8):2008-2010. PubMed ID: 29214881
    [No Abstract]   [Full Text] [Related]  

  • 18. [EVI1 and its role in myelodysplastic syndrome, myeloid leukemia and other malignant diseases].
    Fuchs O
    Cas Lek Cesk; 2006; 145(8):619-24. PubMed ID: 16995417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EVI1 overexpression reprograms hematopoiesis via upregulation of Spi1 transcription.
    Ayoub E; Wilson MP; McGrath KE; Li AJ; Frisch BJ; Palis J; Calvi LM; Zhang Y; Perkins AS
    Nat Commun; 2018 Oct; 9(1):4239. PubMed ID: 30315161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Evi1, microRNA-143, K-Ras axis in colon cancer.
    Gao JS; Zhang Y; Tang X; Tucker LD; Tarwater PM; Quesenberry PJ; Rigoutsos I; Ramratnam B
    FEBS Lett; 2011 Feb; 585(4):693-9. PubMed ID: 21276449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.